These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 1877870)
21. A cell-based screening to detect inhibitors of BRAF signaling pathway. Asami Y; Mori M; Koshino H; Sekiyama Y; Teruya T; Simizu S; Usui T; Osada H J Antibiot (Tokyo); 2009 Feb; 62(2):105-7. PubMed ID: 19132054 [No Abstract] [Full Text] [Related]
22. Non-clonogenic, in vitro assays for predicting sensitivity to cancer chemotherapy. Weisenthal LM; Su YZ; Duarte TE; Nagourney RA Prog Clin Biol Res; 1988; 276():75-92. PubMed ID: 3174684 [No Abstract] [Full Text] [Related]
23. [Mechanism of arsenic compound resistance in prokaryotes and eukaryotes]. Wysocki R; Bobrowicz P; Ułaszewski S Postepy Biochem; 1999; 45(4):304-12. PubMed ID: 10786374 [No Abstract] [Full Text] [Related]
24. Screening for apoptosis inducers in microbial products and induction of apoptosis by cytostatin. Yamazaki K; Amemiya M; Ishizuka M; Takeuchi T J Antibiot (Tokyo); 1995 Oct; 48(10):1138-40. PubMed ID: 7490221 [TBL] [Abstract][Full Text] [Related]
25. Effect of antimetabolites and thymidine blockage on the induction of differentiation of HL-60 cells by retinoic acid or 1 alpha,25-dihydroxyvitamin D3. Ishikura H; Okazaki T; Mochizuki T; Izumi Y; Tashima M; Sawada H; Uchino H Exp Hematol; 1985 Nov; 13(10):981-8. PubMed ID: 3932088 [TBL] [Abstract][Full Text] [Related]
26. Microbial persistence and the road to drug resistance. Cohen NR; Lobritz MA; Collins JJ Cell Host Microbe; 2013 Jun; 13(6):632-42. PubMed ID: 23768488 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds. Witte AB; Anestål K; Jerremalm E; Ehrsson H; Arnér ES Free Radic Biol Med; 2005 Sep; 39(5):696-703. PubMed ID: 16085187 [TBL] [Abstract][Full Text] [Related]
28. Chromosomal aberration due to cytostatic agents. Stacher A; Novotny H; Ruzicka F; Schuhfried G Int J Clin Pharmacol; 1974 Jun; 9(4):250-7. PubMed ID: 4422172 [No Abstract] [Full Text] [Related]
29. In vitro and in vivo pharmacological characterizations of the antitumor properties of two new olivacine derivatives, S16020-2 and S30972-1. Malonne H; Farinelle S; Decaestecker C; Gordower L; Fontaine J; Chaminade F; Saucier JM; Atassi G; Kiss R Clin Cancer Res; 2000 Sep; 6(9):3774-82. PubMed ID: 10999772 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole compounds bearing cinnamoyl groups. Nagamura S; Asai A; Amishiro N; Kobayashi E; Gomi K; Saito H J Med Chem; 1997 Mar; 40(6):972-9. PubMed ID: 9083487 [TBL] [Abstract][Full Text] [Related]
31. Protein-polyamine conjugates by transglutaminase 2 as potential markers for antineoplastic screening of natural compounds. Lentini A; Provenzano B; Tabolacci C; Beninati S Amino Acids; 2009 Apr; 36(4):701-8. PubMed ID: 18696180 [TBL] [Abstract][Full Text] [Related]
32. Apoptosis induction with purine analogs on freshly isolated chronic myeloid leukemia cells. Zinzani PL; Martinelli G; Buzzi M; Farabegoli P; Bendandi M; Tura S Haematologica; 1995; 80(4):390-1. PubMed ID: 7590510 [No Abstract] [Full Text] [Related]
33. Effectiveness of 17DMAG, a geldanamycin derivative, in murine acute myeloid leukemia. Panarsky R; Reichert F; Ben-Ishay Z Acta Haematol; 2009; 121(1):32-6. PubMed ID: 19332984 [No Abstract] [Full Text] [Related]
34. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent. Winski SL; Hargreaves RH; Butler J; Ross D Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924 [TBL] [Abstract][Full Text] [Related]
35. Dimethyl titanocene Y: a valuable precursor for libraries of cytotoxic titanocene derivatives. Immel TA; Martin JT; Dürr CJ; Groth U; Huhn T J Inorg Biochem; 2010 Aug; 104(8):863-7. PubMed ID: 20452674 [TBL] [Abstract][Full Text] [Related]
36. Effects of herbimycin A derivatives on growth and differentiation of K562 human leukemic cells. Honma Y; Kasukabe T; Hozumi M; Shibata K; Omura S Anticancer Res; 1992; 12(1):189-92. PubMed ID: 1567167 [TBL] [Abstract][Full Text] [Related]
37. Antitumor compounds from actinomycetes: from gene clusters to new derivatives by combinatorial biosynthesis. Olano C; Méndez C; Salas JA Nat Prod Rep; 2009 May; 26(5):628-60. PubMed ID: 19387499 [TBL] [Abstract][Full Text] [Related]
38. Antibacterial properties and toxicity of Atuna racemosa extract depend on kernel maturity. Buenz EJ; Tillner JE; Limburg P; Bauer BA J Ethnopharmacol; 2007 May; 111(3):592-7. PubMed ID: 17321090 [TBL] [Abstract][Full Text] [Related]
39. [Antifungal effect of phenolic and carotenoids extracts from chiltepin (Capsicum annum var. glabriusculum) on Alternaria alternata and Fusarium oxysporum]. Rodriguez-Maturino A; Troncoso-Rojas R; Sánchez-Estrada A; González-Mendoza D; Ruiz-Sanchez E; Zamora-Bustillos R; Ceceña-Duran C; Grimaldo-Juarez O; Aviles-Marin M Rev Argent Microbiol; 2015; 47(1):72-7. PubMed ID: 25705046 [TBL] [Abstract][Full Text] [Related]
40. Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a novel antineoplastic agent. Geroni C; Ripamonti M; Arrigoni C; Fiorentini F; Capolongo L; Moneta D; Marchini S; Della Torre P; Albanese C; Lamparelli MG; Ciomei M; Rossi R; Caruso M Cancer Res; 2001 Mar; 61(5):1983-90. PubMed ID: 11280756 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]